Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMs Intl. Regulatory News (MSI)

Share Price Information for Ms Intl. (MSI)

Share Price is delayed by 15 minutes
Get Live Data
1,610.00    20.00 (1.26%)
Bid:
1,590.00
Ask:
1,630.00
Spread: 40.00 (2.516%)
Market Cap: £264.52m
MSI Live PriceLast checked at - London Stock Exchange

Intraday Ms Intl. Share Chart

Annual Financial Report

22 Jun 2023 07:00

RNS Number : 5145D
MS International PLC
22 June 2023
Β 

Β 

Chairman's statement

Β 

Β 

Β 

Results and Review

Β 

It is pleasing to report that the year ended April 2023 was one of further, considerable progress for the Company, even if this may not yet be immediately apparent from the results.

A delay by a customer in taking delivery of a significant contract, relating to the first sales of our 'VSHORAD' counter drone land-based weapon system, because of the continuing war in Europe, meant that, although the equipment was virtually complete and ready for despatch, it could not be delivered before our year end. I am confident this will be fully resolved shortly, but the timing issue negatively impacted the year's reported figures.

Β 

Accordingly, a pre-tax profit of Β£5.08m (2022-Β£5.97m) was achieved on increased revenue of Β£83.96m (2022-Β£74.53m). Basic earnings per share amounted to 25.6p (2022-30.9p).

Β 

More significantly, the value of the Group's order book has almost doubled over the period to stand at a record Β£115 million at the year end (2022-Β£64 million) while the balance sheet remained strong with total cash of Β£15.52m (2022-Β£19.25m).

Β 

'Defence'

Β 

Another year of record revenue for this division, complemented by the successful launch of our first 'in-house', developed, land-based military product namely 'VSHORAD'. This was designed and produced by us as an effective counter to the many threats posed to strategic infrastructure by drone warfare.

Β 

Following extensive and comprehensive performance proving trials, we were delighted to have been awarded our first order for the supply of seven 'VSHORAD' systems to an overseas customer.

Β 

Meantime, our determined endeavours in the United States are being rewarded. We continue to make positive headway towards our goal to gain appropriate US military product approval for our MSI-DS 30mm naval gun system following rigorous testing trials conducted on our weapon system.

Β 

'Forgings'

Β 

This was another good business performance from our manufacturing operations based in the UK, the United States and Brazil, at a time when not only we, but also our many international customers, were focused on seeking to realign raw material and component availability to match current demand, following the disruptions inflicted by the global pandemic.

Β 

Β 'Petrol Station Superstructures'

Β 

High levels of business activity across the markets we serve and a dynamic performance from our UK and Polish operations, resulted in both sales and profitability exceeding expectations whilst delivering strong cash positions at the year end.

Β 

With many years of experience in constructing petrol station superstructures, not only in the UK but also in mainland Europe, we are extremely well placed to address a changing marketplace that is reflecting the demands of an ever-increasing number of electric vehicles. Forecourt operators are intensifying their efforts to upgrade sites to become broader 're-fuelling - hubs' that can facilitate a wide variety of liquid fuels, under-canopy electric charging and vehicle valeting combined with increasing facilities for retail shopping and roadside convenience food.Β 

Β 

'Corporate Branding'

Β 

Our UK operations have continued to expand and prosper, providing our petrol station forecourt customers with a quality service for both new projects and the important maintenance and repair of existing site branding.

Β 

In contrast, we experienced a much slower recovery in business activity in our Netherlands based mainland Europe operations which was disappointing and is accordingly being addressed.Β 

Β 

Β 

Outlook

Β 

'Defence'

Β 

I am pleased to report that we have recently received encouraging confirmation that matters have been resolved relating to the delayed significant contract caused by the continuing war in Europe. We expect to receive payment shortly and then the equipment can be delivered.

Β 

Following the successful launch of our 'VSHORAD' counter drone land-based weapon system with this first order, there continues to be considerable international market interest and excitement that, we believe, should result in a significant number of further sales opportunities. In this regard, we are pleased to report that we have received a new order to supply a number of these systems with a contract value of circa Β£54m.

Β 

Regarding the ongoing opportunities in the US, we cautiously believe that we are well placed to be awarded a contract to supply our MSI-DS 30mm naval weapon system to the US Navy. We have been invited to visit the US to continue commercial negotiations.

Β 

In the meantime, we continue to invest in expanding the Defence business. The ongoing refurbishment and reorganisation of our Norwich manufacturing and weapon assembly facility is central to achieving that objective.

Β 

Β 

'Forgings'

Β 

This division already holds a strong international market presence and excellent reputation as an all-round, top-quality supplier of forged fork-arms for the global materials handling industry.

Β 

We believe that, with the continuing planned investment in upgrading facilities and manufacturing equipment across our plants, we shall continue to perform at an outstanding and acceptable level.

Β 

'Petrol Station Superstructures'

Β 

Forecourt operators are adapting very positively to the rising number of electric vehicles by increasing the number of roof covered charging points and reorganising site layout to accommodate a complete range of motor vehicle refuelling facilities. MSI, with a wealth of experience and detailed construction records for thousands of petrol station sites, remains well placed to provide an excellent and efficient service to the market.

Β 

'Corporate Branding'

Β 

Our UK operation will continue to consolidate and grow its current leading position in the UK market.

Β 

Summary

Β 

We perceive that we are achieving a significant, upward step change in the further development of the Company that will again bring additional rewards and success for the business. I look to the future with confidence.

Β 

All matters considered the Board recommends the payment of a final dividend of 13p per share (2022-7.5p) making a total for the year of 15p (2022-9.25p).

The dividend is expected to be paid on the 18th of August 2023 to those shareholders on the register at the close of business on the 6th July 2023.

Β 

Β 

Β 

Michael Bell

21st June 2023

Β 

Β 

Β 

Β 

MS INTERNATIONAL plcΒ 

Β 

Β 

Michael Bell

Β 

Tel: 01302 322133

Β 

Shore Capital (Nominated Adviser and Broker)

Β 

Β 

Patrick Castle

Β 

Tel: 020 7408 4090

Daniel Bush

Β 

Β 

Copies of this announcement are available from the Company's registered office at MS INTERNATIONAL plc, Balby Carr Bank, Doncaster, DN4 8DH, England. The Notice of AGM will be posted to shareholders on or before 17th July, 2023. The full Annual Report and Accounts will be posted to shareholders in the week commencing 17th July, 2023 at the latest. They will be made available on the Company's website at www.msiplc.com and will be delivered to the Registrar of Companies after it has been laid before the Company's members at the Annual General Meeting to be held on 9th August, 2023 at The Holiday Inn, Warmsworth, Doncaster.

Β 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

Β 

Consolidated income statement

Β 

For the year ended 30th April, 2023

2023

Β 

2022

Continuing operations

Total

Β 

Total

Β£'000

Β 

Β£'000

Revenue

83,956

Β 

74,524

Cost of sales

(60,556)

Β 

(54,121)

Gross profit

23,400

Β 

20,403

Distribution costs

(3,402)

(3,304)

Administrative expenses

(14,748)

Β 

(12,097)

Other operating income

-Β 

Β 

1,185

(18,150)

Β 

(14,216)

Group operating profit

5,250

Β 

6,187

Share of net loss of joint venture

(36)

Β 

-

Interest received

134

1

Interest paid

(134)

(95)

Other finance costs - pensions

(136)

Β 

(126)

(136)

Β 

(220)

Profit before taxation

5,078

Β 

5,967

Taxation

(963)

Β 

(1,035)

Profit for the year attributable to equity holders of the parent

4,115

Β 

4,932

Basic earnings per share

25.6p

Β 

30.9p

Diluted earnings per share

24.2p

Β 

29.6p

Consolidated statement of comprehensive income

Β 

For the year ended 30th April, 2023

2023

Β 

2022

Total

Β 

Total

Β£'000

Β 

Β£'000

Profit for the year attributable to equity holders of the parent

Β 

4,115

Β 

4,932

Exchange differences on retranslation of foreign operations

Β 

Β 

97

Β 

(603)

Net other comprehensive gain/(loss) to be reclassified to profit or loss in subsequent years

Β 

97

Β 

(603)

Remeasurement (losses)/gains on defined benefit pension scheme

(35)

Β 

1,601

Deferred tax on remeasurement on defined benefit pension scheme

9

Β 

(145)

Revaluation of land and buildings

Β -

Β 

3,868

Deferred tax on revaluation surplus on land and buildings

(252)

Β 

(798)

Net other comprehensive (loss)/income not being reclassified to profit or loss in subsequent years

Β 

(278)

4,526

Total comprehensive income for the year attributable to equity holders of the parent

Β 

3,934

Β 

8,885

Β 

Β 

Consolidated and company statement of changes in equity

For the year ended 30th April, 2023

Share capital

Capital redemption reserve

Other reserves

Revaluation reserve

Special reserve

Currency translation reserve

Treasury shares

Retained earnings

Total shareholders' funds

Β 

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β 

(a) Group

Β 

At 30th April, 2021

1,784

957

2,815

6,055

1,629

186

(2,789)

20,399

31,036

Profit for the year

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

4,932

4,932

Other comprehensive income/(loss)

-Β 

-Β 

-Β 

3,868

-Β 

(603)

-Β 

658

3,923

Total comprehensive income/(loss)

-Β 

-Β 

-Β 

3,868

-Β 

(603)

-Β 

5,590

Β 

8,855

Dividends paid

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

(1,316)

(1,316)

At 30th April, 2022

1,784

957

2,815

9,923

1,629

(417)

(2,789)

24,673

38,575

Profit for the year

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

4,115

4,115

Other comprehensive income/(loss)

-Β 

-Β 

-Β 

-Β 

-Β 

97

-Β 

(278)

(181)

Total comprehensive income/(loss)

-Β 

-Β 

-Β 

-Β 

-Β 

97

-Β 

3,837

3,934

Share option expense

-Β 

-Β 

-

-Β 

-

-Β 

-Β 

86

86

Exercise of share options

-Β 

-Β 

-

-Β 

-

-Β 

408

(408)

-Β 

Dividends paid

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

(1,520)

(1,520)

At 30th April, 2023

Β 

1,784

Β 

957

Β 

2,815

9,923

Β 

1,629

Β 

(320)

Β 

(2,381)

Β 

26,668

Β 

41,075

(b) Company

Β 

At 30th April, 2021

1,784

957

7,620

-Β 

1,629

-Β 

(2,789)

16,581

25,782

Profit for the year

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

3,362

3,362

Other comprehensive income

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

1,232

1,232

Total comprehensive income

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

4,594

4,594

Dividends paid

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

(1,316)

(1,316)

At 30th April, 2022

1,784

957

7,620

-Β 

1,629

-Β 

(2,789)

19,859

29,060

Profit for the year

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

305

305

Other comprehensive loss

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

(1)

(1)

Total comprehensive income

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

304

304

Share option expense

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

86

86

Exercise of share options

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

408

(408)

-Β 

Dividends paid

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

(1,520)

(1,520)

At 30th April, 2023

Β 

1,784

Β 

957

Β 

7,620

-Β 

Β 

1,629

Β 

-Β 

Β 

(2,381)

Β 

18,321

Β 

27,930

Β 

Β 

Consolidated and company statements of financial position

At 30th April, 2023

Group

Β 

Company

Β 

2023

Β 

2022

2023

Β 

2022

Β£'000

Β 

Β£'000

Β£'000

Β 

Β£'000

ASSETS

Β 

Non-current assets

Β 

Property, plant and equipment

24,886

Β 

24,537

1,161

Β 

1,017

Right-of-use assets

1,162

Β 

1,479

4,571

Β 

5,029

Intangible assets

2,396

Β 

3,002

Β -Β 

Β 

Β -Β 

Investments in subsidiaries

Β -Β 

Β 

Β -Β 

15,669

Β 

18,126

Investment in joint venture

Β -Β 

Β 

34

Β -Β 

Β 

Β -Β 

Deferred income tax asset

1,677

Β 

1,435

1,216

Β 

1,374

30,121

Β 

30,487

22,617

Β 

25,546

Current assets

Β 

Inventories

24,764

Β 

16,327

2,765

Β 

2,592

Trade and other receivables

9,031

Β 

12,754

14,344

Β 

15,612

Contract assets

144

Β 

1,773

Β -Β 

Β 

Β -Β 

Cash and cash equivalents

12,336

Β 

18,092

8,016

Β 

3,258

Restricted cash held in Escrow

2,917

Β 

1,158

Β -Β 

Β 

Β -Β 

49,192

Β 

50,104

25,125

Β 

21,462

TOTAL ASSETS

Β 

79,313

Β 

80,591

47,742

Β 

47,008

EQUITY AND LIABILITIES

Β 

Equity

Β 

Share capital

1,784

Β 

1,784

1,784

Β 

1,784

Capital redemption reserve

957

Β 

957

957

Β 

957

Other reserves

2,815

Β 

2,815

7,620

Β 

7,620

Revaluation reserve

9,923

Β 

9,923

Β -Β 

Β 

Β -Β 

Special reserve

1,629

Β 

1,629

1,629

Β 

1,629

Currency translation reserve

(320)

Β 

(417)

Β -Β 

Β 

Β -Β 

Treasury shares

(2,381)

Β 

(2,789)

(2,381)

Β 

(2,789)

Retained earnings

26,668

Β 

24,673

18,321

Β 

19,859

TOTAL EQUITY SHAREHOLDERS' FUNDS

Β 

41,075

Β 

38,575

27,930

Β 

29,060

Non-current liabilities

Β 

Defined benefit pension liability

4,216

Β 

4,720

4,216

Β 

4,720

Deferred income tax liability

2,943

Β 

2,578

Β -Β 

Β 

Β -Β 

Lease liabilities

829

Β 

1,158

4,388

Β 

4,807

7,988

Β 

8,456

8,604

Β 

9,527

Current liabilities

Β 

Trade and other payables

15,286

Β 

14,878

9,933

Β 

7,392

Contract liabilities

14,585

Β 

18,329

856

Β 

622

Lease liabilities

379

Β 

353

419

Β 

407

30,250

Β 

33,560

11,208

Β 

8,421

TOTAL EQUITY AND LIABILITIES

Β 

79,313

Β 

80,591

47,742

Β 

47,008

Β 

Consolidated and company cash flow statements

Β 

Β 

For the year ended 30th April, 2023

Β 

Group

Β 

Company

Β 

Β 

2023

Β 

2022

2023

Β 

2022

Β£'000

Β 

Β£'000

Β£'000

Β 

Β£'000

Profit/(loss) before taxation

5,078

Β 

5,967

(1,233)

Β 

2,509

Adjustments to reconcile profit/(loss) before taxation to cash generated from operating activities:

Β 

Depreciation charge of owned assets and right-of-use assets

2,044

Β 

1,746

965

Β 

931

Amortisation charge

239

Β 

227

-Β 

Β 

-Β 

Impairment of goodwill

390

Β 

349

-Β 

Β 

-Β 

Impairment of investment

-Β 

Β 

-Β 

2,457

Β 

-Β 

Profit on disposal of property, plant and equipment

(107)

Β 

(169)

(66)

Β 

(163)

Share option expense

86

Β 

-Β 

86

Β 

-Β 

Share of net loss of joint venture

36

Β 

-Β 

-Β 

Β 

-Β 

Finance costs

136

Β 

220

246

Β 

292

Foreign exchange losses

(369)

Β 

(142)

-Β 

Β 

-Β 

Increase in inventories

(8,326)

Β 

(3,657)

(173)

Β 

(1,094)

Decrease/(increase) in receivables

5,510

Β 

(930)

1,268

Β 

344

(Decrease)/increase in payables

(5)

Β 

1,340

2,194

Β 

1,518

(Decrease)/increase in progress payments

(3,726)

Β 

(3,660)

234

Β 

(252)

Pension fund deficit reduction payments

(675)

Β 

(900)

(675)

Β 

(900)

Cash generated from operating activities

Β 

311

Β 

391

5,303

Β 

3,185

Net interest (received)/paid

50

Β 

(43)

44

Β 

(1)

Taxation (paid)/received

(758)

Β 

(447)

(363)

Β 

151

Net cash (outflow)/inflow from operating activities

Β 

(397)

Β 

(99)

4,984

Β 

3,335

Investing activities

Β 

Dividends received from subsidiaries

-Β 

Β 

-Β 

2,439

Β 

1,249

Purchase of property, plant and equipment

(1,971)

Β 

(2,703)

(705)

Β 

(578)

Purchase of intangible assets

-Β 

Β 

(54)

-Β 

Β 

-Β 

Proceeds on disposal of property, plant and equipment

237

Β 

227

120

Β 

185

(Increase)/decrease in cash held in the Escrow account maturing in more than 90 days

(1,759)

Β 

5,007

-Β 

Β 

-Β 

Net cash (outflow)/inflow from investing activities

(3,493)

Β 

2,477

1,854

Β 

856

Financing activities

Β 

Lease payments

(415)

Β 

(405)

(560)

Β 

(560)

Dividends paid

(1,520)

Β 

(1,316)

(1,520)

Β 

(1,316)

Net cash outflow from financing activities

Β 

(1,935)

Β 

(1,721)

(2,080)

Β 

(1,876)

(Decrease)/increase in cash and cash equivalents

Β 

(5,825)

Β 

657

4,758

Β 

2,315

Opening cash and cash equivalents

18,092

Β 

17,390

3,258

Β 

943

Exchange differences on cash and cash equivalents

69

Β 

45

-Β 

Β 

-Β 

Closing cash and cash equivalents

Β 

12,336

Β 

18,092

8,016

Β 

3,258

Β 

The financial information set out above does not constitute the Company's statutory accounts for the periods ended 30th April, 2023 or 30th April, 2022 but is derived from those accounts. Statutory accounts for 2022 have been delivered to the Registrar of Companies and those for 2023 will be delivered following the Company's Annual General Meeting. The auditors have reported on those accounts; their reports were unqualified and did not contain a statement under section 498 (2) or (3) of the Companies Act 2006.

1. Segment information

Β 

The following table presents revenue and profit and certain assets and liability information regarding the Group's divisions for the years ended 30th April, 2023 and 30th April, 2022. The reporting format is determined by the differences in manufacture and services provided by the Group. The 'Defence' division is engaged in the design, manufacture, and service of defence equipment. The 'Forgings' division is engaged in the manufacture of forgings. The 'Petrol Station Superstructures' division is engaged in the design, manufacture, construction, branding, maintenance, and restyling of petrol station superstructures. The 'Corporate Branding' division is engaged in the design, manufacture, installation, and service of corporate brandings.

Β 

Management monitors the operating results of its business units separately for the purpose of making decisions about resource allocation and performance assessment. Group financing (including finance costs and finance revenue) and income taxes are managed on a group basis and are therefore not allocated to operating segments.

Β 

'Defence'

'Forgings'

'Petrol Station

'Corporate

Total

Superstructures'

Branding'

2023

Β 

2022

2023

Β 

2022

2023

Β 

2022

2023

Β 

2022

2023

Β 

2022

Β£'000

Β 

Β£'000

Β£'000

Β 

Β£'000

Β£'000

Β 

Β£'000

Β£'000

Β 

Β£'000

Β£'000

Β 

Β£'000

Segmental revenue

Β 

Total revenue

32,433

Β 

30,219

23,266

Β 

16,482

16,336

Β 

15,143

12,412

Β 

13,009

84,447

Β 

74,853

Revenue from other segments

-Β 

Β 

-Β 

-Β 

Β 

-Β 

(316)

Β 

(245)

(175)

Β 

(84)

(491)

Β 

(329)

Revenue from external customers

32,433

Β 

30,219

23,266

Β 

16,482

16,020

Β 

14,898

12,237

Β 

12,925

83,956

Β 

74,524

Segment result

Β 

Operating profit/(loss)

2,023

Β 

4,123

3,864

Β 

2,245

2,053

Β 

1,074

(2,690)

Β 

(1,255)

5,250

Β 

6,187

Share of net loss of joint venture

(36)

Β 

-Β 

Net finance costs

(136)

Β 

(220)

Profit before taxation

5,078

Β 

5,967

Taxation

(963)

Β 

(1,035)

Profit for the year

Β 

4,115

Β 

4,932

Segmental assets

Β 

Assets attributable to segments

28,145

Β 

33,393

9,394

Β 

7,883

10,732

Β 

9,380

6,744

Β 

8,050

55,015

Β 

58,706

Unallocated assets*

24,298

Β 

21,885

Total assets

79,313

Β 

80,591

Segmental liabilities

Β 

Liabilities attributable to segments

19,012

Β 

23,643

3,942

Β 

3,547

3,402

Β 

3,109

3,391

Β 

3,591

29,747

Β 

33,890

Unallocated liabilities*

8,491

Β 

8,126

Total liabilities

38,238

Β 

42,016

Other segmental information

Β 

Capital expenditure

1,065

Β 

1,933

213

Β 

389

353

Β 

195

340

Β 

186

1,971

Β 

2,703

Depreciation

322

Β 

210

644

Β 

561

728

Β 

714

350

Β 

261

2,044

Β 

1,746

Amortisation

18

Β 

10

-Β 

Β 

-Β 

43

Β 

43

178

Β 

174

239

Β 

227

Impairment

-Β 

Β 

-Β 

-Β 

Β 

-Β 

-Β 

Β 

-Β 

390

Β 

349

390

Β 

349

Β 

* Unallocated assets include certain fixed assets (including all UK properties), current assets and deferred income tax assets. Unallocated liabilities include the defined pension benefit scheme liability, the deferred income tax liability, and certain current liabilities.

Assets and liabilities attributable to segments comprise the assets and liabilities of each segment adjusted to reflect the elimination of the cost of investment in subsidiaries and the provision of financing loans provided by MS INTERNATIONAL plc.

Revenue between segments is determined on an arm's length basis. Segment results, assets, and liabilities include items directly attributable to the segment as well as those that can be allocated on a reasonable basis.

Geographical analysis

Β 

The following table presents revenue and expenditure and certain assets and liabilities information by geographical segment for the years ended 30th April, 2023 and 30th April, 2022. The Group's geographical segments are based on the location of the Group's assets.

United Kingdom

Europe

USA

South America

Total

2023

2022

2023

Β 

2022

2023

Β 

2022

2023

Β 

2022

2023

Β 

2022

Β£'000

Β£'000

Β£'000

Β 

Β£'000

Β£'000

Β 

Β£'000

Β£'000

Β 

Β£'000

Β£'000

Β 

Β£'000

External revenue by origin

51,424

41,665

12,333

Β 

11,599

17,270

Β 

18,917

2,929

Β 

2,343

83,956

Β 

74,524

Non-current assets

20,529

20,160

3,365

Β 

4,327

6,107

Β 

5,913

120

Β 

87

30,121

Β 

30,487

Current assets

40,269

37,235

5,158

Β 

6,147

2,844

Β 

6,024

921

Β 

698

49,192

Β 

50,104

Liabilities

23,281

28,380

3,345

Β 

4,112

11,380

Β 

9,223

232

Β 

301

38,238

Β 

42,016

Capital expenditure

1,569

2,377

162

Β 

133

240

Β 

193

-Β 

Β 

-Β 

1,971

Β 

2,703

Β 

Revenue disaggregated by destination is shown as follows:

2023

Β 

2022

Β£'000

Β 

%

Β 

Β£'000

%

United Kingdom

28,354

Β 

34%

Β 

31,287

42%

Europe

21,158

Β 

25%

Β 

17,103

23%

USA

17,270

Β 

21%

Β 

19,406

26%

South America

3,036

Β 

3%

Β 

2,421

3%

Rest of World

14,138

Β 

17%

Β 

4,307

6%

Total revenue

83,956

Β 

100%

Β 

74,524

100%

The Group's largest customer, which is reported in the 'Defence' division, contributed 12.6% to the Group's revenue (2022 - 14.2% in the 'Defence' division from a different customer). There are no other customers which contributed more than 10% to the Group's revenue (2022 - 11.4% in the 'Defence' division).

Β 

During the year, the Group recognised Β£2.2m of profit in relation to a contract in the 'Defence' division that was terminated in April 2023.

Β 

Β 

2. Other operating income

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

2023

2022

Β 

Β 

Β 

Β 

Β 

Β 

Β£'000

Β£'000

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Settlement of contractual dispute

Β 

Β 

Β 

Β 

Β 

-

1,185

Β 

Β 

Β 

Β 

Β 

Β 

-

1,185

Β 

Β 

Β 

Β 

Β 

Β 

Β 

In the prior year the Group settled a contractual dispute, the terms of which are confidential. The amount received was recognised in other income. The Group incurred Β£0.6m of legal costs in the prior year in relation to this matter. These costs were included in administrative expenses.

Β 

Β 

Β 

Β 

Β 

Β 

3. Employee information

Β 

Β 

Β 

Β 

Β 

The average number of employees, including executive directors, during the year was as follows:

Β 

Β 

Β 

Β 

Β 

Group

Β 

Company

Β 

2023

2022

2023

Β 

2022

Β 

Number

Number

Number

Β 

Number

Production

Β 

263

252

78

Β 

74

Technical

Β 

71

71

21

Β 

23

Distribution

Β 

26

26

2

Β 

2

Administration

Β 

94

98

39

Β 

39

Β 

454

447

140

Β 

138

(a) Staff costs

Including executive directors, employment costs were as follows:

Group

Β 

Company

2023

2022

2023

Β 

2022

Β£'000

Β£'000

Β£'000

Β 

Β£'000

Wages and salaries

21,024

18,942

7,415

Β 

7,139

Covid-19 job retention scheme income

-Β 

(1,636)

-Β 

Β 

-Β 

Social security costs

3,853

3,233

822

Β 

722

Pension costs

667

570

423

Β 

352

Share options expense

30

Β 

Β 

29

30

Β 

29

25,574

21,138

8,690

Β 

8,242

The Covid-19 job retention scheme income has been received in the following countries:

2023

Β 

2022

Β£'000

Β 

Β£'000

The Netherlands

-Β 

Β 

1,310

USA

-Β 

Β 

251

Poland

-Β 

Β 

75

-Β 

Β 

1,636

Β 

(b) Directors' emoluments

2023

Β 

2022

Β£'000

Β 

Β£'000

Aggregate directors' emoluments

2,072

Β 

1,810

Pension contributions

65

Β 

52

Gain on exercise of share options

1,042

Β 

-

3,179

Β 

1,862

Β 

On 8th December, 2022 two directors exercised LTIP share options totalling 250,000 at an exercise price of Β£0 per share. The gain on the exercise of these share options is the difference between market price at the date of exercise of Β£4.17 and the exercise price of Β£0 per share.

Β 

4. (a) Taxation

Β 

The charge for taxation comprises:

2023

Β 

2022

Β£'000

Β 

Β£'000

Current tax

Β 

United Kingdom corporation tax

860

Β 

667

Foreign corporation tax

311

Β 

120

Adjustments in respect of previous years

(76)

Β 

(10)

Group current tax expense

1,095

Β 

777

Deferred tax

Β 

Origination and reversal of temporary differences

(122)

Β 

261

Adjustments in respect of previous years

(2)

Β 

(5)

Adjustments in respect of difference in applicable tax rate

(8)

Β 

2

Group deferred tax (credit)/expense

(132)

Β 

258

Total tax expense on profit

Β 

963

Β 

1,035

Tax relating to items charged to other comprehensive income:

2023

2022

Β£'000

Β£'000

Deferred tax charged through other comprehensive income

Β 

Deferred tax on measurement gains on pension scheme current year

(9)

Β 

145

Deferred tax on revaluation surplus on land and buildings

252

Β 

798

Deferred tax expense in the Consolidated statement of comprehensive income

243

Β 

943

(b) Factors affecting the tax charge for the year

Β 

Β 

The tax charge assessed for the year is lower than (2022: lower than) the standard rate of corporation tax in the UK of 19.5% (2022 - 19%). The differences are explained below:

Β 

2023

Β 

2022

Β 

Β£'000

Β 

Β£'000

Β 

Β 

Profit before tax

5,078

Β 

5,967

Β 

Profit multiplied by standard rate of corporation tax of 19.5% (2022 - 19%)

990

Β 

1,134

Β 

Β 

Β 

Effects of:

Β 

Expenses not deductible for tax purposes

35

29

Β 

Permanent timing differences

(293)

(276)

Β 

Adjustments in respect of overseas tax rates

125

132

Β 

Dual residency tax

232

Β 

29

Β 

Current tax adjustment in respect of previous years

(76)

Β 

(10)

Β 

UK deferred tax not previously recognised

(40)

Β 

-Β 

Β 

Deferred tax adjustment in respect of previous years

(2)

Β 

(5)

Β 

Deferred tax adjustment in respect of different applicable rates

(8)

Β 

2

Β 

Total taxation expense for the year

963

Β 

1,035

Β 

Β 

Β 

(c) Factors affecting future tax charge

Β 

Β 

On 1st April 2023 the rate of corporation tax in the UK increased from 19% to 25%. Therefore, deferred income tax has been provided at 25%.

Β 

Β 

5. Earnings per share

Β 

The calculation of basic earnings per share of 25.6p (2022 - 30.9p) is based on the profit for the year attributable to equity holders of the parent of Β£4,115,000 (2022 - Β£4,932,000) and on a weighted average number of ordinary shares in issue of 16,045,581 (2022 - 15,949,691). At 30th April, 2023 there were 1,270,000 (2022 - 1,055,000) dilutive shares on option with a weighted average effect of 980,875 (2022 - 716,575) giving a diluted earnings per share of 24.2p (2022 - 29.6p).

2023

Β 

2022

Number of ordinary shares in issue at start of the year

17,841,073

Β 

17,841,073

Cancellation of ordinary shares during the year

-Β 

Β 

-Β 

Number of ordinary shares in issue at the end of the year

17,841,073

Β 

17,841,073

Β 

Weighted average number of shares in issue

17,841,073

Β 

17,841,073

Less weighted average number of shared held in the ESOT

(245,048)

Β 

(245,048)

Less weighted average number of shares purchased by the Company

(1,550,444)

Β 

(1,646,334)

Weighted average number of shares to be used in basic EPS calculation

16,045,581

Β 

15,949,691

Weighted average number of the 1,270,000 (2022 - 1,055,000) dilutive shares

980,875

Β 

716,575

Weighted average diluted shares

17,026,456

Β 

16,666,266

Profit for the year attributable to equity holders of the parent in Β£

4,115,000

Β 

4,932,000

Basic earnings per share

25.6p

Β 

30.9p

Diluted earnings per share

24.2p

Β 

29.6p

6. Dividends paid and proposed

Β 

2023

Β 

2022

Β£'000

Β 

Β£'000

Declared and paid during the year:

Final dividend for 2022: 7.5p (2021 - 6.5p)

1,196

Β 

1,037

Interim dividend for 2023: 2p (2022 - 1.75p)

324

Β 

279

1,520

Β 

1,316

Β 

Β 

Proposed for approval by shareholders at the AGM:

Β 

Β 

Final dividend for 2023: 13p (2022 - 7.5p)

2,106Β 

Β 

1,196

Β 

7. Trade and other receivables

Group

Β 

Company

Β 

2023

Β 

2022

2023

Β 

2022

Β£'000

Β 

Β£'000

Β£'000

Β 

Β£'000

Trade receivables (net of allowance for expected credit losses)

6,931

Β 

10,167

2,756

Β 

2,366

Amounts owed by subsidiary undertakings

-

Β 

-

11,356

Β 

13,024

Amounts owed by joint venture

-

Β 

228

-Β 

Β 

-

Prepayments

1,027

Β 

1,352

228

Β 

218

Other receivables

1,071

Β 

1,001

4

Β 

4

Income tax receivable

2

Β 

6

-

Β 

-Β 

9,031

Β 

12,754

14,344

Β 

15,612

(a) Trade receivables

Trade receivables are denominated in the following currencies:

Group

Β 

Company

Β 

2023

Β 

2022

2023

Β 

2022

Β£'000

Β 

Β£'000

Β£'000

Β£'000

Sterling

3,946

Β 

5,554

1,739

Β 

1,576

Euro

1,973

Β 

1,786

1,017

Β 

790

US dollar

736

Β 

2,406

-

Β 

-

Other currencies

276

Β 

421

-

Β 

-

6,931Β 

Β 

10,167Β 

2,756Β 

Β 

2,366Β 

Trade receivables are non-interest bearing, generally have 30 day terms, and are shown net of provision for expected credit losses. The aged analysis of trade receivables after provision for expected credit losses is as follows:

Β 

Β 

Group

Β 

Company

2023

2022

2023

2022

Β 

Β 

Β 

Β 

Β 

Β 

Β£'000

Β 

Β£'000

Β 

Β£'000

Β 

Β£'000

Not past due

5,059Β 

7,234Β 

2,282Β 

2,316Β 

< 30 days

1,745Β 

2,062Β 

482Β 

24Β 

30-60 days

90Β 

64Β 

18Β 

19Β 

60-90 days

37Β 

11Β 

-Β 

8Β 

> 90 days

-Β 

796Β 

(26)

(1)

Total

6,931Β 

10,167Β 

2,756Β 

2,366Β 

In the Group, trade receivables with a nominal value of Β£36,000 (2022 - Β£52,000) were impaired and fully provided as at 30th April, 2023. During the year, expected credit losses of Β£42,000 (2022 - Β£20,000) were recovered and expected credit losses of Β£26,000 (2022 - Β£29,000) were incurred.

In the Company, trade receivables with a nominal value of Β£16,000 (2022 - Β£33,000) were impaired and fully provided as at 30th April, 2023. During the year, expected credit losses of Β£30,000 (2022 - Β£7,000) were recovered and expected credit losses of Β£13,000 (2022 - Β£29,000) were incurred.

(b) Amounts owed by joint venture

Amounts owed by joint venture are non-interest bearing and have 30 day terms. The aged analysis of amounts owed by joint venture net of provision for expected credit losses as follows:

Β 

Β 

Group

2023

2022

Β£'000

Β£'000

Not past due

-Β 

135Β 

< 30 days

-Β 

47Β 

30-60 days

-Β 

34Β 

60-90 days

-Β 

12Β 

Total

-Β 

-

228

At 30th April, 2023 there was no provision for expected credit losses relating to amounts owed by joint venture (2022 - nil).

(c) Intercompany receivables

All amounts due from Group companies are repayable on demand and are not charged interest. The majority of intercompany balances are to group entities with liquid assets and are capable of being repaid on demand. An impairment charge of Β£1,470,000 relating to 'MSI-Sign Group BV' and 'MSI-Sign Group GmbH' has been recognised on intercompany receivables in the company (2022 - nil).

There are loans to 'MS INTERNATIONAL Estates Limited' and 'MS INTERNATIONAL Estates LLC', which although repayable on demand, are supported by properties, which will not be immediately realisable. The directors have assessed the likelihood of default and the loss in the event of default as well as the balance at the reporting date and conclude that there is no material impairment of the receivable.

The amounts receivable at the reporting date can be categorised as:

Company

2023

Β 

2022

Β£'000

Β 

Β£'000

Amounts due from companies backed by liquid assets

3,607

Β 

3,880

Amounts due from 'MS INTERNATIONAL Estates Limited'

5,461

Β 

5,925

Amounts due from 'MS INTERNATIONAL Estates LLC'

2,288

Β 

3,219

11,356

Β 

13,024

Β 

8. Cash and cash equivalents

Β 

Group

Β 

Company

Β 

2023

Β 

2022

2023

Β 

2022

Β£'000

Β 

Β£'000

Β£'000

Β 

Β£'000

Cash at bank and in hand

12,336

Β 

18,092

8,016

Β 

3,258

Restricted cash held in Escrow - maturing in more than 90 days

2,917

Β 

1,158

-

Β 

Β -Β 

Total cash

15,253

Β 

19,250

8,016

Β 

3,258

The balance held in Escrow provides security to Lloyds Bank plc in respect of specific guarantees, indemnities, and performance bonds given by the Group in the ordinary course of business.

9. Net funds

Β 

(a) Analysis of net funds

Β 

Β 

Β 

Β 

Β 

Β 

Group

Β 

Company

Β 

2023

Β 

2022

2023

Β 

2022

Β£'000

Β 

Β£'000

Β£'000

Β 

Β£'000

Β 

Β 

Β 

Β 

Cash and cash equivalents

12,336

Β 

18,092

8,016

Β 

3,258

Restricted cash held in Escrow

2,917

Β 

1,158

-Β 

Β 

-Β 

Lease liabilities

(1,208)

Β 

(1,511)

(4,807)

Β 

(5,214)

14,045

Β 

17,739

3,209

Β 

(1,956)

(b) Group movement in net funds

Β 

Cash and cash equivalent

Β 

Restricted cash held in Escrow

Β 

Lease liabilities

Β 

Total

At 30th April, 2021

17,390

6,165

(545)

23,010

Cash flows

657

(5,007)

405

(3,945)

Foreign exchange adjustments

45

-Β 

7

52

New leases

-Β 

-Β 

(1,327)

(1,327)

Other changes

-Β 

-Β 

(51)

(51)

At 30th April, 2022

Β 

Β 

Β 

Β 

Β 

Β 

18,092

1,158

(1,511)

17,739

Cash flows

(5,825)

1,759

415

(3,651)

Foreign exchange adjustments

69

-Β 

(61)

8

Other changes

-Β 

-Β 

(51)

(51)

At 30th April, 2023

12,336

Β 

2,917

Β 

(1,208)

Β 

14,045

Β 

(c) Company movement in net funds

Β 

Β 

Β 

Cash and cash equivalents

Β 

Lease liabilities

Β 

Total

At 30th April, 2021

943

(5,609)

(4,666)

Cash flows

2,315

560

2,875

Other changes

-Β 

(165)

(165)

At 30th April, 2022

Β 

Β 

Β 

Β 

Β 

3,258

(5,214)

(1,956)

Cash flows

4,758

560

5,318

Other changes

-Β 

(153)

(153)

At 30th April, 2023

Β 

Β 

8,016

Β 

(4,807)

Β 

3,209

Β 

Β 

9. Reserves

Β 

Capital redemption reserve

Β 

The balance classified as capital redemption reserve represents the nominal value of issued share capital of the Company, repurchased.

Other reserves

Β 

Following the transfer of assets held at valuation by the Company to a subsidiary company, a reserve has been created which is non-distributable. This is equal to the revaluation reserve previously arising.

Additionally, it includes the non-distributable retained reserve for the revaluation reserve previously showing in the Company for properties now transferred to other members of the Group.

Revaluation reserve

Β 

The asset revaluation reserve is used to record increases in the fair value of land and buildings and decreases to the extent that such decrease relates to an increase on the same assets previously recognised in equity.

Special reserve

Β 

The special reserve is a distributable reserve created following the cancellation of a share premium account by way of court order in March 1993.

Currency translation reserve

Β 

The foreign currency translation reserve is used to record exchange differences arising from the translation of the financial statements of foreign subsidiaries. It is also used to record the effect of hedging net investments in foreign operations.

Treasury shares

Β 

The treasury share reserve is detailed as follows:

2022

Β 

2021

Β£'000

Β 

Β£'000

Β 

Β 

Employee Share Ownership Trust (a)

100

Β 

100

Shares in treasury (b)

2,689

Β 

2,959

2,789

Β 

3,059

(a) The Employee Share Ownership Trust ("ESOT") provides for the issue of options over ordinary shares in the Company to Group employees, including executive directors, at the discretion of the Remuneration Committee. The trustee of the ESOT is Ocorian Ltd, an independent company registered in Jersey.

The trust has purchased an aggregate 245,048 (2022 - 245,048) ordinary shares, which represents 1.49% (2022 - 1.51%) of the issued share capital of the Company excluding treasury shares at an aggregate cost of Β£100,006. The market value of the shares at 30th April, 2023 was Β£1,250,000 (2022 - Β£728,000). The Company has not made any payments (2022 - nil) into the ESOT bank accounts during the year. Details of the outstanding share options for directors are included in the Directors' remuneration report.

The assets, liabilities, income, and costs of the ESOT have been incorporated into the Company's financial statements. Total ESOT costs charged to the income statement in the year amounts to Β£8,000 (2022 - Β£1,000). During the year, 20,000 options have been granted over shares (2022 - nil) and 250,000 options on shares were exercised (2022 - nil).

(b) The Company made the following purchases and cancellations of its own 10p ordinary shares to be held in Treasury:

Number

Β 

Β£'000

Β 

Β 

Β 

Purchase of 1,000,000 shares from the Group's pension scheme on 11th December, 2013

1,000,000

1,722

Purchase of 646,334 shares on 30th January, 2014

646,334

1,237

Purchase of 555,000 shares on 15th January, 2021

555,000

636

Consideration paid for purchase of own shares

2,201,334

Β 

3,595

Cancellation of 555,000 shares at weighted average rate

(555,000)

(906)

Exercise of LTIP share options

(250,000)

(408)

Net value of treasury shares

1,396,334

Β 

2,281

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FR FFFFIRSILFIV
Date   Source Headline
29th Apr 20264:05 pmRNSExercise of Options & TVR
14th Apr 20261:50 pmRNSGrant of Options & Director/PDMR Shareholdings
31st Mar 20264:04 pmRNSDirector/PDMR Shareholding
16th Mar 20263:44 pmRNSDirector/PDMR Shareholding
16th Mar 20263:44 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:40 pmRNSExercise of Options & TVR
23rd Feb 20265:54 pmRNSDirector/PDMR Shareholdings
2nd Feb 20263:35 pmRNSGrant of Options & Director Shareholding
19th Jan 20265:35 pmRNSExercise of Options, TVR & Director Shareholdings
14th Jan 20267:00 amRNSHalf-year Report
13th Nov 20255:11 pmRNSNotice of Results
30th Oct 20255:26 pmRNSHolding(s) in Company
27th Oct 20257:00 amRNSDirector/PDMR Shareholding
2nd Oct 202512:49 pmRNSDirector/PDMR Shareholding and Total Voting Rights
1st Oct 20257:00 amRNSUNITED STATES NAVY CONTRACTS
9th Sep 20252:09 pmRNSExercise of Options, TVR & Director Shareholding
22nd Aug 20252:53 pmRNSExercise of Options, TVR & Director Shareholdings
13th Aug 20255:19 pmRNSExercise of Options, TVR & Director Shareholding
6th Aug 20252:18 pmRNSResult of AGM
6th Aug 202511:00 amRNSAGM Statement
18th Jul 20257:00 amRNSConfirmation of Director Appointment
17th Jul 20254:46 pmRNSExercise of Options & TVR
15th Jul 20254:01 pmRNSExercise of Options, TVR & Director Shareholdings
9th Jul 20254:51 pmRNSExercise of Options, TVR & Director Shareholding
4th Jul 20254:35 pmRNSExercise of Options & TVR
3rd Jul 20254:03 pmRNSExercise of Options & TVR
2nd Jul 20255:17 pmRNSExercise of Options, TVR & Director Shareholding
1st Jul 20254:01 pmRNSExercise of Options, TVR & Director Shareholding
30th Jun 20257:00 amRNSFinal Results
13th Feb 20254:30 pmRNSExercise of Options and Total Voting Rights
21st Jan 20252:00 pmRNSConfirmation of Director Appointment
20th Jan 20254:01 pmRNSDirector/PDMR Shareholding
20th Jan 20251:18 pmRNSDirector/PDMR Shareholding
14th Jan 20254:35 pmRNSDirector/PDMR Shareholding and Total Voting Rights
10th Dec 20244:01 pmRNSDirector/PDMR Shareholding
6th Dec 20247:00 amRNSHalf-year Report
22nd Oct 20243:57 pmRNSTotal Voting Rights
1st Oct 20242:37 pmRNSDirector/PDMR Shareholding
16th Sep 20243:36 pmRNSDirectors' Shareholdings
6th Sep 20242:50 pmRNSTransaction in Own Shares & Director Shareholding
13th Aug 20243:52 pmRNSExercise of Options and Total Voting Rights
9th Aug 202410:49 amRNSDirector/PDMR Shareholding
7th Aug 20243:20 pmRNSExercise of Options and Total Voting Rights
2nd Aug 20243:48 pmRNSDirector/PDMR Shareholding
25th Jul 20242:00 pmRNSResult of AGM
17th Jul 202411:23 amRNSExercise of Options, TVR & Director Shareholding
15th Jul 20242:38 pmRNSDirector/PDMR Shareholding and Total Voting Rights
11th Jul 202412:00 pmRNSTransaction in own shares and exercise of options
4th Jul 20241:20 pmRNSExercise of Options and Total Voting Rights
1st Jul 20244:22 pmRNSExercise of Options, Director Shareholding & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.